Blog
RSS FeedPosted by Michael Wonder on 05 Nov 2019
Prescription drug prices are falling at historic levels thanks to Trump Administration policies
5 November 2019 - While the media continues to claim prescription drug prices are rising, a recent Council of Economic ...
Posted by Michael Wonder on 03 Nov 2019
International impact of external reference pricing: should national policy makers care?
3 November 2019 - External reference pricing is widely used to regulate drug prices. ...
Posted by Michael Wonder on 03 Nov 2019
White House distances itself from Pelosi plan to lower drug prices
2 November 2019 - The White House is distancing itself from Speaker Nancy Pelosi’s plan to lower drug prices, emphasising ...
Posted by Michael Wonder on 03 Nov 2019
Pelosi calls pharma’s bluff on drug prices
1 November 2019 - Allowing Medicare to negotiate with drugmakers would barely slow the pace of innovation. ...
Posted by Michael Wonder on 03 Nov 2019
Sometimes drug prices are too low
31 October 2019 - Washington’s efforts to keep medications affordable have had unintended consequences. ...
Posted by Michael Wonder on 03 Nov 2019
Innovative drugs save lives only if people can afford them
2 November 2019 - Under a new bill, a handful of new drugs might never get produced. That would be worth ...
Posted by Michael Wonder on 31 Oct 2019
Insurance, pharma figures spar over drug price legislation’s innovation impact
30 October 2019 - Pharmaceutical and health insurance industry representatives on Wednesday sparred over the potential impacts of legislation to ...
Posted by Michael Wonder on 30 Oct 2019
House Democrats clash over Pelosi's drug pricing bill
30 October 2019 - Moderate and progressive House Democrats are clashing with each other over changes to Speaker Nancy Pelosi’s ...
Posted by Michael Wonder on 30 Oct 2019
Forced drug prices are not the answer to health care costs
30 October 2019 - Stick around long enough and all bad ideas have a way of repeating themselves. ...
Posted by Michael Wonder on 29 Oct 2019
NHS bill for US drugs 'could soar under post-Brexit trade deal'
28 October 2019 - Dispatches investigation finds 'drug pricing' has been discussed in six initial meetings between trade officials from the ...
Posted by Michael Wonder on 29 Oct 2019
How the Prescription Drug Pricing Reduction Act can reduce drug costs
28 October 2019 - Bipartisan Rx brings transparency to drug pricing. ...
Posted by Michael Wonder on 29 Oct 2019
UK officials discussed NHS at ‘secret’ meetings with US drug companies as part of trade talks
29 October 2019 - Envoys sidestep ban on discussing drug prices by referring to controversial subject ‘valuing innovation’. ...
Posted by Michael Wonder on 29 Oct 2019
We need a cure for the arrogance of drug price control advocates
29 October 2019 - “Three hundred forty-five billion dollars in savings versus the cost of eight to 15 fewer drugs over ...
Posted by Michael Wonder on 29 Oct 2019
Costly prescription eye treatment highlights a loophole in Canada’s drug-price regulation process
28 October 2019 - The Ontario government has begun covering $100,000-a-year eye drops for an ultrarare disease, bringing relief to ...
Posted by Michael Wonder on 28 Oct 2019
Intraparty disputes dim outlook for drug price legislation
28 October 2019 - White House, Congress seek action this year, but conflicts and possible impeachment present logistical hurdles. ...